Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an ED

American Journal of Emergency Medicine

Volumn 36, Issue 6, 2018, Pages 916-921

  Trabattoni, E ^a   Le, V ^a   Pilmis, B ^a   Pean de Ponfilly, G ^a   Caisso, C ^a   Couzigou, C ^a   Vidal, B ^a   Mizrahi, A ^a   Ganansia, O ^a   Le Monnier, A ^a   Lina, B ^b   Nguyen Van, J C ^a  

^a SAINT JOSEPH HOSPITAL   (France)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; VIRUS DNA;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY WARD; EPIDEMIC; FEMALE; FLU LIKE SYNDROME; FRANCE; GOLD STANDARD; HOSPITALIZATION; HUMAN; INFLUENZA; INTERMETHOD COMPARISON; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; POINT OF CARE TESTING; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERTIARY CARE CENTER; GENETICS; HOSPITAL EMERGENCY SERVICE; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MIDDLE AGED; RETROSPECTIVE STUDY; VIROLOGY;

ADULT; AGED; DNA, VIRAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FRANCE; HUMANS; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POINT-OF-CARE TESTING; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 85033557986     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2017.10.046     Document Type: Article

References (43)

1. WHO, Influenza (seasonal). http://www.who.int/mediacentre/factsheets/fs211/en/, 2016. (Accessed 12 May 2016)
2. Vanhems, P., Benet, T., Munier-Marion, E., Nosocomial influenza: encouraging insights and future challenges. Curr Opin Infect Dis 29 (2016), 366–372.
3. Kovacs, G., Kalo, Z., Jahnz-Rozyk, K., et al. Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother 10 (2014), 428–440.
4. Allard, R., Leclerc, P., Tremblay, C., Tannenbaum, T.N., Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 33 (2010), 1491–1493.
5. Metersky, M.L., Masterton, R.G., Lode, H., File, T.M. Jr., Babinchak, T., Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis 16 (2012), e321–31.
6. Molbak, K., Espenhain, L., Nielsen, J., et al. Excess mortality among the elderly in European countries, December 2014 to February 2015. Euro Surveill, 20, 2015.
7. Chartrand, C., Leeflang, M.M., Minion, J., Brewer, T., Pai, M., Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 156 (2012), 500–511.
8. Baas, C., Barr, I.G., Fouchier, R.A., Kelso, A., Hurt, A.C., A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013. Euro Surveill, 18, 2013.
9. Chan, M.C., Lee, N., Ngai, K.L., Leung, T.F., Chan, P.K., Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children. J Clin Microbiol 52 (2014), 497–501.
10. Jennings, L.C., Anderson, T.P., Werno, A.M., Beynon, K.A., Murdoch, D.R., Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections. Pediatr Infect Dis J 23 (2004), 1003–1007.
11. Dugas, A.F., Valsamakis, A., Atreya, M.R., et al. Clinical diagnosis of influenza in the ED. Am J Emerg Med 33 (2015), 770–775.
12. Petric, M., Comanor, L., Petti, C.A., Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 194:Suppl. 2 (2006), S98–110.
13. Schanzer, D.L., Schwartz, B., Impact of seasonal and pandemic influenza on emergency department visits, 2003–2010, Ontario, Canada. Acad Emerg Med 20 (2013), 388–397.
14. Bouscambert, M., Valette, M., Lina, B., Rapid bedside tests for diagnosis, management, and prevention of nosocomial influenza. J Hosp Infect 89 (2015), 314–318.
15. Dugas, A.F., Coleman, S., Gaydos, C.A., Rothman, R.E., Frick, K.D., Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. Ann Emerg Med 62 (2013), 80–88.
16. Leibovici, L., Paul, M., Should we recommend neuroaminidase inhibitors for influenza?. Clin Microbiol Infect 20 (2014), O979–80.
17. Bell, J., Bonner, A., Cohen, D.M., et al. Multicenter clinical evaluation of the novel Alere i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol 61 (2014), 81–86.
18. Hurtado, J.C., Mosquera, M.M., de Lazzari, E., et al. Evaluation of a new, rapid, simple test for the detection of influenza virus. BMC Infect Dis, 15, 2015, 44.
19. Nguyen Van, J.C., Camelena, F., Dahoun, M., et al. Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. Diagn Microbiol Infect Dis 85 (2016), 19–22.
20. Nie, S., Roth, R.B., Stiles, J., et al. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol 52 (2014), 3339–3344.
21. InVS, Bulletin épidémiologique grippe. http://invs.santepubliquefrance.fr//Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Grippe/Grippe-generalites/Donnees-de-surveillance/Archives/Bulletin-epidemiologique-grippe.-Point-au-27-avril-2016, 2016. (Accessed 12 May 2016)
22. WHO, WHO information for molecular diagnosis of influenza virus in humans — update. http://www.who.int/influenza/gisrs_laboratory/molecular_diagnosis/en/, 2014. (Accessed 12 May 2014)
23. InVS, Bulletin épidémiologique grippe. 2016.
24. ECDC, Seasonal influenza 2015–2016 in the EU/EEA Countries. http://ecdc.europa.eu/en/publications/publications/seasonal-influenza-risk-assessment-2015-2016.pdf, 2016. (Accessed 12 May 2016)
25. Vaux, S., Van Cauteren, D., Guthmann, J.P., et al. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health, 11, 2011, 30.
26. Tuppin, P., Samson, S., Weill, A., Ricordeau, P., Allemand, H., Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. Vaccine 29 (2011), 4632–4637.
27. Jeong, H.W., Heo, J.Y., Park, J.S., Kim, W.J., Effect of the influenza virus rapid antigen test on a physician's decision to prescribe antibiotics and on patient length of stay in the emergency department. PLoS One, 9, 2014, e110978.
28. Fagbuyi, D.B., Brown, K.M., Mathison, D.J., et al. A rapid medical screening process improves emergency department patient flow during surge associated with novel H1N1 influenza virus. Ann Emerg Med 57 (2011), 52–59.
29. Soto, M., Sampietro-Colom, L., Vilella, A., et al. Economic impact of a new rapid PCR assay for detecting influenza virus in an emergency department and hospitalized patients. PLoS One, 11, 2016, e0146620.
30. Bonner, A.B., Monroe, K.W., Talley, L.I., Klasner, A.E., Kimberlin, D.W., Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 112 (2003), 363–367.
31. Lee, N., Choi, K.W., Chan, P.K., et al. Outcomes of adults hospitalised with severe influenza. Thorax 65 (2010), 510–515.
32. Salgado, C.D., Farr, B.M., Hall, K.K., Hayden, F.G., Influenza in the acute hospital setting. Lancet Infect Dis 2 (2002), 145–155.
33. Cowling, B.J., Ip, D.K., Fang, V.J., et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun, 4(1935), 2013.
34. Lindsley, W.G., Blachere, F.M., Beezhold, D.H., et al. Viable influenza A virus in airborne particles expelled during coughs versus exhalations. Influenza Other Respi Viruses 10 (2016), 404–413.
35. Gonzales, R., Malone, D.C., Maselli, J.H., Sande, M.A., Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 33 (2001), 757–762.
36. Tillekeratne, L.G., Bodinayake, C.K., Nagahawatte, A., et al. Use of rapid influenza testing to reduce antibiotic prescriptions among outpatients with influenza-like illness in Southern Sri Lanka. Am J Trop Med Hyg 93 (2015), 1031–1037.
37. Ozkaya, E., Cambaz, N., Coskun, Y., Mete, F., Geyik, M., Samanci, N., The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department. Acta Paediatr 98 (2009), 1589–1592.
38. FDA, FDA grants first CLIA waiver for nucleic acid-based flu diagnostic test. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm429127.htm, 2015. (Accessed 12 May 2016)
39. Sohn, A.J., Hickner, J.M., Alem, F., Use of point-of-care tests (POCTs) by US primary care physicians. J Am Board Fam Med 29 (2016), 371–376.
40. Hojat, K., Duppenthaler, A., Aebi, C., Impact of the availability of an influenza virus rapid antigen test on diagnostic decision making in a pediatric emergency department. Pediatr Emerg Care 29 (2013), 696–698.
41. Poehling, K.A., Zhu, Y., Tang, Y.W., Edwards, K., Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med 160 (2006), 713–718.
42. Parker, B.T., Marco, C., Emergency department length of stay: accuracy of patient estimates. West J Emerg Med 15 (2014), 170–175.
43. Bleustein, C., Rothschild, D.B., Valen, A., Valatis, E., Schweitzer, L., Jones, R., Wait times, patient satisfaction scores, and the perception of care. Am J Manag Care 20 (2014), 393–400.